Author:
Sebastián Olga Gavín,Calvo José Manuel,Dobón-Rebollo Manuela,Amarilla Irene,Fernández Nuria,Sancho Luis Ignacio,Cuesta Isabel,Franco-García Esther,Pérez Ángeles,Lacalle Laura
Subject
Microbiology (medical),Immunology,Immunology and Allergy
Reference31 articles.
1. Franchini M, Liumbruno GM, Bonfanti B, et al. The evolution of anticoagulant therapy. Blood Transfuse. 2016;14(2):175-184.
2. New oral anticoagulants: their advantages and disadvantages compared with vitamin K antagonists in the prevention and treatment of patients with thromboembolic events;Mekaj;Ther Clin Risk Manag,2015
3. Time-Driven Activity-Based Cost Analysis for Outpatient Anticoagulation Therapy: Direct Costs in a Primary Care Setting with Optimal Performance;Kaplan;J Med Econ,2019
4. Direct Oral Anticoagulant- or Warfarin-Related Major Bleeding: Characteristics, Reversal Strategies, and Outcomes From a Multicenter Observational Study;Xu;Chest,2017
5. Caldeira D, Barra M, Ferreira A, et al. Systematic review with meta‐analysis: the risk of major gastrointestinal bleeding with non‐vitamin K antagonist oral anticoagulants. Aliment Pharmacol Ther. 2015;42(11-12):1239-1249.